Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDER PAN study of dabigatran etexilate and rivaroxaban absorption in adults with short bowel syndrome on long-term parenteral nutrition
NL-OMON26342Phase 1Recruiting
- Sponsor
- Academic Medical Center
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of rivaroxaban and dabigatran in catheter-related thrombosis (CRT) and Phlebothrombosis (2 arms), sponsored by Academic Medical Center. Primary endpoint: Pharmacokinetic and pharmacodynamic parameters of rivaroxaban and dabigatran etexilate. Started Oct 2013; status: recruiting.
02
Drugs
rivaroxabandabigatran
03
Conditions
catheter-related thrombosis (CRT)Phlebothrombosis
Beyond the preview
Go deeper on NL-OMON26342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26342.